These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33961120)

  • 21. Clinical profiles of patients with surgically resected pheochromocytoma and paraganglioma.
    Lee SH; Park JH; Lee JY; Lee SR; Rhee KS; Chae JK; Kim WH; Sul JY; Oh JK; Kwon HJ; Lee JH; Seong IW
    Korean J Intern Med; 2020 Mar; 35(2):351-359. PubMed ID: 30808127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years.
    Hamidi O; Young WF; Iñiguez-Ariza NM; Kittah NE; Gruber L; Bancos C; Tamhane S; Bancos I
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3296-3305. PubMed ID: 28605453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraganglioma in pregnancy: interdisciplinary management during pregnancy.
    Nieto AJ; Trochez L; Ramírez D; Arguello P; Guzman G; Pachajoa H; Escobar Vidarte MF
    Gynecol Endocrinol; 2019 Jul; 35(7):567-570. PubMed ID: 30786782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative hemodynamic instability in pheochromocytoma and sympathetic paraganglioma patients.
    Kim JH; Lee HC; Kim SJ; Yoon SB; Kong SH; Yu HW; Chai YJ; Choi JY; Lee KE; Lee KW; Min SK; Shin CS; Park KJ
    Sci Rep; 2021 Sep; 11(1):18574. PubMed ID: 34535733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma.
    Bliziotis NG; Kluijtmans LAJ; Soto S; Tinnevelt GH; Langton K; Robledo M; Pamporaki C; Engelke UFH; Erlic Z; Engel J; Deutschbein T; Nölting S; Prejbisz A; Richter S; Prehn C; Adamski J; Januszewicz A; Reincke M; Fassnacht M; Eisenhofer G; Beuschlein F; Kroiss M; Wevers RA; Jansen JJ; Deinum J; Timmers HJLM
    Endocrine; 2022 Jan; 75(1):254-265. PubMed ID: 34536194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamics in Patients With Pheochromocytoma or Paraganglioma Undergoing Non-neuroendocrine Operations.
    Valencia Morales DJ; Laporta ML; Zec S; Yu K; Bancos I; Martin DP; Martin McGrew YN; Weingarten TN; Hanson AC; Sun J; Schroeder DR; Sprung J
    J Surg Res; 2022 Sep; 277():189-199. PubMed ID: 35500514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of
    Jaiswal SK; Sarathi V; Malhotra G; Hira P; Shah R; Patil VA; Dalvi A; Prakash G; Lila AR; Shah NS; Bandgar T
    J Pediatr Endocrinol Metab; 2021 Jan; 34(1):109-119. PubMed ID: 33180042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Pheochromocytoma or Paraganglioma on Bone Metabolism: A Systemic Review and Meta-analysis.
    Dutta D; Nagendra L; Chandran M; Sharma M; Bhattacharya S; Mukhopadhyay S
    J Clin Densitom; 2024; 27(3):101501. PubMed ID: 38796986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients.
    Calsina B; Currás-Freixes M; Buffet A; Pons T; Contreras L; Letón R; Comino-Méndez I; Remacha L; Calatayud M; Obispo B; Martin A; Cohen R; Richter S; Balmaña J; Korpershoek E; Rapizzi E; Deutschbein T; Vroonen L; Favier J; de Krijger RR; Fassnacht M; Beuschlein F; Timmers HJ; Eisenhofer G; Mannelli M; Pacak K; Satrústegui J; Rodríguez-Antona C; Amar L; Cascón A; Dölker N; Gimenez-Roqueplo AP; Robledo M
    Genet Med; 2018 Dec; 20(12):1652-1662. PubMed ID: 30008476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups.
    Taïeb D; Jha A; Treglia G; Pacak K
    Endocr Relat Cancer; 2019 Nov; 26(11):R627-R652. PubMed ID: 31561209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral pheochromocytoma and paraganglioma: a rare cause of cardiomyopathy.
    Koshy AN; Cheng VE; Sajeev JK; Venkataraman P; Profitis K
    Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):705. PubMed ID: 27013246
    [No Abstract]   [Full Text] [Related]  

  • 32. Preoperative α-blockade versus no blockade for pheochromocytoma-paraganglioma patients undergoing surgery: a systematic review and updated meta-analysis.
    Wang J; Liu Q; Jiang S; Zhang J; He J; Li Y; Wang D
    Int J Surg; 2023 May; 109(5):1470-1480. PubMed ID: 37037514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-6 producing pheochromocytoma/paraganglioma: case series from a tertiary referral centre for pheochromocytomas and paragangliomas.
    Meijs AC; Schroijen MA; Snel M; Corssmit EPM
    J Endocrinol Invest; 2021 Oct; 44(10):2253-2259. PubMed ID: 33715142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current experts' views on precision nuclear medicine imaging of phaeochromocytoma and paraganglioma.
    Taïeb D; Pacak K
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2223-2224. PubMed ID: 31332495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
    Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K
    J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population.
    Choi H; Kim KJ; Hong N; Shin S; Choi JR; Kang SW; Lee ST; Rhee Y
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):858-872. PubMed ID: 33397040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pheochromocytoma/Paraganglioma (PPGL): A Misdiagnosed Cause of Hypertension during Pregnancy.
    Giorgi RB; Aroucha PT; Favreto TM; Montero MF; Velloni JMF; Korkes I; Ferreira EN; Olivati C; Lima JV; Kater CE; Costa-Barbosa FA
    Case Rep Obstet Gynecol; 2024; 2024():6655229. PubMed ID: 38572182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ensemble Machine Learning Model Incorporating Radiomics and Body Composition for Predicting Intraoperative HDI in PPGL.
    Fu Y; Wang X; Yi X; Guan X; Chen C; Han Z; Gong G; Yin H; Liu L; Chen BT
    J Clin Endocrinol Metab; 2024 Jan; 109(2):351-360. PubMed ID: 37708346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pheochromocytoma and Paraganglioma Patients With Poor Survival Often Show Brown Adipose Tissue Activation.
    Abdul Sater Z; Jha A; Hamimi A; Mandl A; Hartley IR; Gubbi S; Patel M; Gonzales M; Taïeb D; Civelek AC; Gharib AM; Auh S; O'Mara AE; Pacak K; Cypess AM
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1176-85. PubMed ID: 31903484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.